DermaSensor Presents Study Results on Melanoma Detection in a Medicare Population at American Dermoscopy Meeting
DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and Older MIAMI, July 13, 2023, Business Wire — DermaSensor Inc., a health technology company equipping primary care physicians …